134 related articles for article (PubMed ID: 35339340)
21. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
[TBL] [Abstract][Full Text] [Related]
22. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
23. Preoperative sarcopenia is associated with poor overall survival in pancreatic cancer patients following pancreaticoduodenectomy.
Peng YC; Wu CH; Tien YW; Lu TP; Wang YH; Chen BB
Eur Radiol; 2021 Apr; 31(4):2472-2481. PubMed ID: 32974690
[TBL] [Abstract][Full Text] [Related]
24. Predictive value of sarcopenia and visceral obesity for postoperative pancreatic fistula after pancreaticoduodenectomy analyzed on clinically acquired CT and MRI.
Jang M; Park HW; Huh J; Lee JH; Jeong YK; Nah YW; Park J; Kim KW
Eur Radiol; 2019 May; 29(5):2417-2425. PubMed ID: 30406311
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials.
Charette N; Vandeputte C; Ameye L; Bogaert CV; Krygier J; Guiot T; Deleporte A; Delaunoit T; Geboes K; Van Laethem JL; Peeters M; Demolin G; Holbrechts S; Flamen P; Paesmans M; Hendlisz A
BMC Cancer; 2019 Feb; 19(1):134. PubMed ID: 30744591
[TBL] [Abstract][Full Text] [Related]
26. The Role of Visceral Obesity, Sarcopenia and Sarcopenic Obesity on Surgical Outcomes After Liver Resections for Colorectal Metastases.
Runkel M; Diallo TD; Lang SA; Bamberg F; Benndorf M; Fichtner-Feigl S
World J Surg; 2021 Jul; 45(7):2218-2226. PubMed ID: 33842995
[TBL] [Abstract][Full Text] [Related]
27. Host phenotype is associated with reduced survival independent of tumour biology in patients with colorectal liver metastases.
van Dijk DPJ; Krill M; Farshidfar F; Li T; Rensen SS; Olde Damink SWM; Dixon E; Sutherland FR; Ball CG; Mazurak VC; Baracos VE; Bathe OF
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):123-130. PubMed ID: 30378742
[TBL] [Abstract][Full Text] [Related]
28. Clinical Impact of Muscle Quantity and Quality in Colorectal Cancer Patients: A Propensity Score Matching Analysis.
Okugawa Y; Toiyama Y; Yamamoto A; Shigemori T; Yin C; Narumi A; Omura Y; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Kobayashi M; Araki T; McMillan DC; Miki C; Kusunoki M
JPEN J Parenter Enteral Nutr; 2018 Nov; 42(8):1322-1333. PubMed ID: 29761898
[TBL] [Abstract][Full Text] [Related]
29. Impact of sarcopenic obesity on 30-day mortality in critically ill patients with intra-abdominal sepsis.
Ji Y; Cheng B; Xu Z; Ye H; Lu W; Luo X; Fu S; Fang X
J Crit Care; 2018 Aug; 46():50-54. PubMed ID: 29677586
[TBL] [Abstract][Full Text] [Related]
30. Body composition and outcome in patients undergoing resection of colorectal liver metastases.
van Vledder MG; Levolger S; Ayez N; Verhoef C; Tran TC; Ijzermans JN
Br J Surg; 2012 Apr; 99(4):550-7. PubMed ID: 22246799
[TBL] [Abstract][Full Text] [Related]
31. Impact of Sarcopenic Obesity on Outcomes in Patients Undergoing Hepatectomy for Hepatocellular Carcinoma.
Kobayashi A; Kaido T; Hamaguchi Y; Okumura S; Shirai H; Yao S; Kamo N; Yagi S; Taura K; Okajima H; Uemoto S
Ann Surg; 2019 May; 269(5):924-931. PubMed ID: 29064889
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of myosteatosis and sarcopenia for elderly patients with colorectal cancer: A large-scale double-center study.
Chen WZ; Shen ZL; Zhang FM; Zhang XZ; Chen WH; Yan XL; Zhuang CL; Chen XL; Yu Z
Surgery; 2022 Oct; 172(4):1185-1193. PubMed ID: 35868905
[TBL] [Abstract][Full Text] [Related]
33. The relationship between tumour stage, systemic inflammation, body composition and survival in patients with colorectal cancer.
McSorley ST; Black DH; Horgan PG; McMillan DC
Clin Nutr; 2018 Aug; 37(4):1279-1285. PubMed ID: 28566220
[TBL] [Abstract][Full Text] [Related]
34. Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer.
Keyl J; Hosch R; Berger A; Ester O; Greiner T; Bogner S; Treckmann J; Ting S; Schumacher B; Albers D; Markus P; Wiesweg M; Forsting M; Nensa F; Schuler M; Kasper S; Kleesiek J
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):545-552. PubMed ID: 36544260
[TBL] [Abstract][Full Text] [Related]
35. Low Muscularity and Myosteatosis Is Related to the Host Systemic Inflammatory Response in Patients Undergoing Surgery for Colorectal Cancer.
Malietzis G; Johns N; Al-Hassi HO; Knight SC; Kennedy RH; Fearon KC; Aziz O; Jenkins JT
Ann Surg; 2016 Feb; 263(2):320-5. PubMed ID: 25643288
[TBL] [Abstract][Full Text] [Related]
36. Sarcopenia and Myosteatosis Predict Adverse Outcomes After Emergency Laparotomy: A Multi-center Observational Cohort Study.
Body S; Ligthart MAP; Rahman S; Ward J; May-Miller P; Pucher PH; Curtis NJ; West MA;
Ann Surg; 2022 Jun; 275(6):1103-1111. PubMed ID: 33914486
[TBL] [Abstract][Full Text] [Related]
37. Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
Donnelly M; Driever D; Ryan ÉJ; Elliott JA; Finnegan J; McNamara D; Murphy I; Conlon KC; Neary PC; Kavanagh DO; O'Riordan JM
Inflamm Bowel Dis; 2023 Oct; ():. PubMed ID: 37861366
[TBL] [Abstract][Full Text] [Related]
38. Visceral obesity, muscle mass and outcome in rectal cancer surgery after neo-adjuvant chemo-radiation.
Heus C; Cakir H; Lak A; Doodeman HJ; Houdijk AP
Int J Surg; 2016 May; 29():159-64. PubMed ID: 27063857
[TBL] [Abstract][Full Text] [Related]
39. Detection of sarcopenic obesity and prediction of long-term survival in patients with gastric cancer using preoperative computed tomography and machine learning.
Kim J; Han SH; Kim HI
J Surg Oncol; 2021 Dec; 124(8):1347-1355. PubMed ID: 34490899
[TBL] [Abstract][Full Text] [Related]
40. The combination of body composition conditions and systemic inflammatory markers has prognostic value for patients with gastric cancer treated with adjuvant chemoradiotherapy.
Li Y; Wang WB; Yang L; Wang QY; Dai J; Xia L; Peng J; Zhou FX; Wei YC; Shi HP
Nutrition; 2022 Jan; 93():111464. PubMed ID: 34678715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
